These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2997470)

  • 1. Humoral immune response to herpes simplex virus type 2 glycoproteins in patients receiving a glycoprotein subunit vaccine.
    Ashley R; Mertz G; Clark H; Schick M; Salter D; Corey L
    J Virol; 1985 Nov; 56(2):475-81. PubMed ID: 2997470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of asymptomatic herpes simplex virus infections after vaccination.
    Ashley R; Mertz GJ; Corey L
    J Virol; 1987 Feb; 61(2):264-8. PubMed ID: 3806788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex virus type-2 glycoprotein-subunit vaccine: tolerance and humoral and cellular responses in humans.
    Mertz GJ; Peterman G; Ashley R; Jourden JL; Salter D; Morrison L; McLean A; Corey L
    J Infect Dis; 1984 Aug; 150(2):242-9. PubMed ID: 6088648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immune response to HSV-1 and HSV-2 viral proteins in patients with primary genital herpes.
    Ashley R; Benedetti J; Corey L
    J Med Virol; 1985 Oct; 17(2):153-66. PubMed ID: 2997384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans.
    Cairns TM; Huang ZY; Whitbeck JC; Ponce de Leon M; Lou H; Wald A; Krummenacher C; Eisenberg RJ; Cohen GH
    J Virol; 2014 Nov; 88(21):12612-22. PubMed ID: 25142599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and latent herpes simplex virus neurological disease in mice immunized with purified virus-specific glycoproteins gB or gD.
    Dix RD; Mills J
    J Med Virol; 1985 Sep; 17(1):9-18. PubMed ID: 2995573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific.
    Cairns TM; Huang ZY; Gallagher JR; Lin Y; Lou H; Whitbeck JC; Wald A; Cohen GH; Eisenberg RJ
    J Virol; 2015 Sep; 89(18):9213-31. PubMed ID: 26109729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes simplex virus (HSV)-specific proliferative and cytotoxic T-cell responses in humans immunized with an HSV type 2 glycoprotein subunit vaccine.
    Zarling JM; Moran PA; Brewer L; Ashley R; Corey L
    J Virol; 1988 Dec; 62(12):4481-5. PubMed ID: 2846864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice.
    Ghiasi H; Kaiwar R; Nesburn AB; Slanina S; Wechsler SL
    J Virol; 1994 Apr; 68(4):2118-26. PubMed ID: 8138996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of glycosylation of herpes simplex virus glycoproteins: identification of antigenic and immunogenic partially glycosylated glycopeptides on the cell surface membrane.
    Glorioso J; Szczesiul MS; Marlin SD; Levine M
    Virology; 1983 Apr; 126(1):1-18. PubMed ID: 6189286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB.
    Kitamura K; Namazue J; Campo-Vera H; Ogino T; Yamanishi K
    Virology; 1986 Feb; 149(1):74-82. PubMed ID: 2418583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection.
    Chan WL; Lukig ML; Liew FY
    J Exp Med; 1985 Oct; 162(4):1304-18. PubMed ID: 2995536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic variants of herpes simplex virus selected with glycoprotein-specific monoclonal antibodies.
    Holland TC; Marlin SD; Levine M; Glorioso J
    J Virol; 1983 Feb; 45(2):672-82. PubMed ID: 6187935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E.
    Hook LM; Huang J; Jiang M; Hodinka R; Friedman HM
    J Virol; 2008 Jul; 82(14):6935-41. PubMed ID: 18480440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A recombinant glycoprotein vaccine for herpes simplex virus type 2: safety and immunogenicity [corrected].
    Langenberg AG; Burke RL; Adair SF; Sekulovich R; Tigges M; Dekker CL; Corey L
    Ann Intern Med; 1995 Jun; 122(12):889-98. PubMed ID: 7755223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of acyclovir treatment of primary genital herpes on the antibody response to herpes simplex virus.
    Ashley RL; Corey L
    J Clin Invest; 1984 Mar; 73(3):681-8. PubMed ID: 6323525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with a cocktail of seven recombinantly expressed HSV-1 glycoproteins protects against ocular HSV-1 challenge more efficiently than vaccination with any individual glycoprotein.
    Ghiasi H; Nesburn AB; Wechsler SL
    Vaccine; 1996 Feb; 14(2):107-12. PubMed ID: 8852405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immune response to herpes simplex virus: comparison of the specificity and relative titers of serum antibodies directed against viral polypeptides following primary herpes simplex virus type 1 infections.
    Eberle R; Mou SW; Zaia JA
    J Med Virol; 1985 Jun; 16(2):147-62. PubMed ID: 2409225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.